MAR With Artificial Gametes: Treatment Characteristics and Their Trade-offs Determining Treatment Preference

NCT02280681 | Active Not Recruiting

• 1 other identifier: S57341
• Study Type: observational
• Target: 400
• Locations: 0 countries
• Sites: N/A

Brief Summary

To gain insight by means of a discrete choice experiment questionnaire into characteristics of medically assisted reproduction (MAR) with artificial gametes (AGs) valued by couples confronted with ovarian failure and their physicians and the trade-offs they make between these treatment characteristics.

Conditions

Ovarian Failure

Keywords

reproductive medicine; artificial gametes; patient preference; decision making

Outcome Measures

Primary Outcomes (1)

• Relative importance of predefined treatment characteristics

  single time point

Secondary Outcomes (1)

• Demographic and self-reported medical data that define the importance of the treatment characteristics

  single time poin

Study Arms (2)

Couples with ovarian failure

Heterosexual couples confronted with infertility due to ovarian failure between the age of 18 and 44 years old treated in the K.U.Leuven and

Other: No intervention, only questionnaire

Clinicians

Clinicians who indicated an interest in reproductive medicine in their membership of the Belgian Society for Reproductive Medicine (BSRM).

Other: No intervention, only questionnaire

Interventions

No intervention, only questionnaire OTHER

No intervention, only questionnaire containing a discrete choice experiment identifying the importance of treatment aspects for deciding between current treatments and possible future treatments with artificial gametes

Clinicians; Couples with ovarian failure

Eligibility Criteria

• Age: 18 Years - 44 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

1. Heterosexual couples confronted with infertility due to ovarian failure between the age of 18 and 44 years old treated in the K.U.Leuven and 2. clinicians who indicated an interest in reproductive medicine in their membership of the Belgian Society for Reproductive Medicine (BSRM).

You may qualify if:

• Heterosexual couples confronted with infertility due to ovarian failure between the age of 18 and 44 years old treated in the K.U.Leuven

Sponsors & Collaborators

• Universitaire Ziekenhuizen KU Leuven: lead

Related Publications (4)

• Hendriks S, Dancet EA, Meissner A, van der Veen F, Mochtar MH, Repping S. Perspectives of infertile men on future stem cell treatments for nonobstructive azoospermia. Reprod Biomed Online. 2014 May;28(5):650-7. doi: 10.1016/j.rbmo.2014.01.011. Epub 2014 Jan 31.

  PMID: 24656558 BACKGROUND

• Boivin J, Bunting L, Collins JA, Nygren KG. International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod. 2007 Jun;22(6):1506-12. doi: 10.1093/humrep/dem046. Epub 2007 Mar 21.

  PMID: 17376819 BACKGROUND

• Harper J, Magli MC, Lundin K, Barratt CL, Brison D. When and how should new technology be introduced into the IVF laboratory? Hum Reprod. 2012 Feb;27(2):303-13. doi: 10.1093/humrep/der414. Epub 2011 Dec 12.

  PMID: 22166806 BACKGROUND

• Ryan M, Farrar S. Using conjoint analysis to elicit preferences for health care. BMJ. 2000 Jun 3;320(7248):1530-3. doi: 10.1136/bmj.320.7248.1530. No abstract available.

  PMID: 10834905 BACKGROUND

MeSH Terms

Conditions

Patient Preference

Condition Hierarchy (Ancestors)

Patient Satisfaction; Treatment Adherence and Compliance; Health Behavior; Behavior

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Target Duration: 1 Day
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 29, 2014
• First Posted: October 31, 2014
• Study Start: October 1, 2014
• Primary Completion: October 1, 2025
• Study Completion: October 1, 2025
• Last Updated: July 15, 2024

Record last verified: 2024-07